Efficacy and Safety Study of F373280
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 135 participants.
Also called NCT01831856
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 135 participants
- Sponsor
- Pierre Fabre Medicament
- Registry
-
NCT01831856 -
2012-003487-48
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Czechia, Hungary, Italy, Poland, Spain
- Registry status
- Completed
Technical summary
Registry record NCT01831856. Randomized; quadruple masking; primary purpose treatment. Start 2013-04 (actual); primary completion 2017-04-03 (actual). Results posted on 2019-07-02.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety Study of F373280
- Condition
- Atrial Fibrillation
- Intervention (Drug)
- 1g of F373280
- Intervention (Drug)
- Placebo
- Lead sponsor
- Pierre Fabre Medicament
Record details
- Record id
cardio:ct-nct01831856- Content hash
5db23fe6829d78306cfb84c60abfc080371d92b9b6a1129aa46b004cf30be168